BPC-157 free base
BPC 157 is a 15-amino acid fragment of a gastric peptide, BPC, with hepatoprotective effects. BPC 157 is a gut peptide and possesses free radical scavenging activity. This peptide stimulates nitric oxide synthase generation and therefore offers gastric cytoprotection. Unlike other peptides, BPC 157 is effective without a carrier. It participates in muscle healing and is used in the treatment of gastrocnemius muscle complex. BPC 157 is a stable gastric pentadecapeptide that exhibit anti-ulcer and wounds/fistulas healing properties. BPC 157 reduces immediate and delayed damage induced brain trauma and improves nerve regeneration after transection. BPC 157 displays antianxiety and antidepressant effects.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD141 |
| CAS # | 137525-51-0 (free base) |
| Pricing | Customizable size, Inquiry |
| Synonym | BPC 157; BPC-157; BPC157; Bpc 15; Bpc-15; Bpc15; Booly protection compound 15; BPC 157 TFA; BPC 157 trifluoroacetic acid |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C62H98N16O22 |
| Exact Mass | 1418.7042 |
| Molecular Weight | 1419.556 |
| Elemental Analysis | C, 52.46; H, 6.96; N, 15.79; O, 24.79 |
| IUPAC/Chemical Name | L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-, |
| InChi Key | HEEWEZGQMLZMFE-RKGINYAYSA-N |
| InChi Code | InChI=1S/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1 |
| SMILES Code | CC(C)[C@@H](C(O)=O)NC([C@H](CC(C)C)NC(CNC([C@H](C)NC([C@H](CC(O)=O)NC([C@H](CC(O)=O)NC([C@H](C)NC([C@H]1N(C([C@H](CCCCN)NC(CNC([C@H]2N(C([C@H]3N(C([C@H]4N(C([C@H](CCC(O)=O)NC(CN)=O)=O)CCC4)=O)CCC3)=O)CCC2)=O)=O)=O)CCC1)=O)=O)=O)=O)=O)=O)=O |
| Appearance | Solid powder |
| Purity | >95% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >3 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Class-2 | Schizophrenia |
| Availability | 2 Weeks |